308430 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Cellbion Co., Ltd. engages in the research and development of imaging agents for diagnosis, cosmetics for hospitals, and functional health foods. It focus on the research and development of prostate cancer treatments. The company was founded by Kwon Kim on July 21, 2010 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
308430 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company